News - Page 34 - Psychedelic Alpha

Read more about the article Numinus Wellness Inc. Reports Q3 2023 Results

Numinus Wellness Inc. Reports Q3 2023 Results

Post published:July 17, 2023
Post category:Press Release

Read more about the article Psychedelic Bulletin #141: Terran’s 4-OH-DiPT Prodrug Patent App.; Generic Ketamine Appears Effective for TRD; VA/DoD Guideline Reviews Psychedelics

Psychedelic Bulletin #141: Terran’s 4-OH-DiPT Prodrug Patent App.; Generic Ketamine Appears Effective for TRD; VA/DoD Guideline Reviews Psychedelics

Post published:July 17, 2023
Post category:Psychedelic Bulletin

Read more about the article COMPASS Pathways announces publication of positive data from treatment-resistant depression phase 2 clinical trial of COMP360 psilocybin alongside antidepressants in Nature journal, Neuropsychopharmacology

COMPASS Pathways announces publication of positive data from treatment-resistant depression phase 2 clinical trial of COMP360 psilocybin alongside antidepressants in Nature journal, Neuropsychopharmacology

Post published:July 17, 2023
Post category:Press Release

Read more about the article FILAMENT HEALTH ANNOUNCES CHANGE OF AUDITOR

FILAMENT HEALTH ANNOUNCES CHANGE OF AUDITOR

Post published:July 15, 2023
Post category:Press Release

Read more about the article Algernon Pharmaceuticals Announces Private Placement and Issuance of Shares in Connection with Financial Advisory Agreement

Algernon Pharmaceuticals Announces Private Placement and Issuance of Shares in Connection with Financial Advisory Agreement

Post published:July 15, 2023
Post category:Press Release

Read more about the article Reunion Neuroscience Inc. Obtains Final Court Order for Proposed Plan of Arrangement

Reunion Neuroscience Inc. Obtains Final Court Order for Proposed Plan of Arrangement

Post published:July 14, 2023
Post category:Press Release

Read more about the article Reunion Neuroscience Inc. Shareholders Approve Proposed Plan of Arrangement

Reunion Neuroscience Inc. Shareholders Approve Proposed Plan of Arrangement

Post published:July 13, 2023
Post category:Press Release

Read more about the article BetterLife Highlights American College of Physicians’ Updated Guidelines for Treating Depression and Announces Closing of Private Placement

BetterLife Highlights American College of Physicians’ Updated Guidelines for Treating Depression and Announces Closing of Private Placement

Post published:July 13, 2023
Post category:Press Release

Read more about the article Opinion paper calls for clarity on the definition of “psychedelic-assisted therapy” using psilocybin

Opinion paper calls for clarity on the definition of “psychedelic-assisted therapy” using psilocybin

Post published:July 13, 2023
Post category:Press Release

Read more about the article Dr. Fatima Cody Stanford, Associate Professor of Medicine and Pediatrics at Harvard Medical School, Joins Clearmind Medicine’s Scientific Advisory Board

Dr. Fatima Cody Stanford, Associate Professor of Medicine and Pediatrics at Harvard Medical School, Joins Clearmind Medicine’s Scientific Advisory Board

Post published:July 11, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.